Northrop Grumman Corporation (BMV:NOC)
Mexico · Delayed Price · Currency is MXN 10,700
0.00 (0.00%)
At close: Aug 8, 2025, 2:00 PM CST
Theseus Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 3,945 | 4,174 | 2,056 | 4,896 | 7,005 | 3,189 | Upgrade |
Depreciation & Amortization | 1,432 | 1,370 | 1,338 | 1,342 | 1,239 | 1,267 | Upgrade |
Loss (Gain) From Sale of Assets | -231 | - | - | - | -1,980 | - | Upgrade |
Stock-Based Compensation | 95 | 101 | 87 | 99 | 94 | 90 | Upgrade |
Other Operating Activities | -880 | -1,531 | 538 | -2,836 | -2,972 | -468 | Upgrade |
Change in Accounts Receivable | -1,324 | -33 | 301 | -690 | -424 | -125 | Upgrade |
Change in Inventory | -62 | -358 | -220 | -205 | -52 | 18 | Upgrade |
Change in Accounts Payable | -87 | -513 | 519 | 572 | 376 | 719 | Upgrade |
Change in Income Taxes | 73 | 1,143 | -658 | -279 | 215 | -238 | Upgrade |
Change in Other Net Operating Assets | 11 | 35 | -86 | 2 | 66 | -147 | Upgrade |
Operating Cash Flow | 2,972 | 4,388 | 3,875 | 2,901 | 3,567 | 4,305 | Upgrade |
Operating Cash Flow Growth | -32.10% | 13.24% | 33.58% | -18.67% | -17.14% | 0.19% | Upgrade |
Capital Expenditures | -1,664 | -1,767 | -1,775 | -1,435 | -1,415 | -1,420 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | 155 | 84 | 205 | Upgrade |
Divestitures | 333 | - | - | - | 3,400 | - | Upgrade |
Investment in Securities | - | - | 197 | - | - | - | Upgrade |
Other Investing Activities | -19 | 18 | -4 | 39 | -11 | 4 | Upgrade |
Investing Cash Flow | -1,350 | -1,749 | -1,582 | -1,241 | 2,058 | -1,211 | Upgrade |
Long-Term Debt Issued | - | 2,495 | 1,995 | - | - | 2,239 | Upgrade |
Total Debt Issued | 1,564 | 2,495 | 1,995 | - | - | 2,239 | Upgrade |
Long-Term Debt Repaid | - | - | -1,050 | - | -2,236 | -1,105 | Upgrade |
Total Debt Repaid | -1,500 | - | -1,050 | - | -2,236 | -1,105 | Upgrade |
Net Debt Issued (Repaid) | 64 | 2,495 | 945 | - | -2,236 | 1,134 | Upgrade |
Repurchase of Common Stock | -1,692 | -2,572 | -1,552 | -1,554 | -3,739 | -556 | Upgrade |
Common Dividends Paid | -1,234 | -1,186 | -1,116 | -1,052 | -983 | -953 | Upgrade |
Other Financing Activities | -133 | -132 | -38 | -7 | -44 | -57 | Upgrade |
Financing Cash Flow | -2,995 | -1,395 | -1,761 | -2,613 | -7,002 | -432 | Upgrade |
Net Cash Flow | -1,373 | 1,244 | 532 | -953 | -1,377 | 2,662 | Upgrade |
Free Cash Flow | 1,308 | 2,621 | 2,100 | 1,466 | 2,152 | 2,885 | Upgrade |
Free Cash Flow Growth | -50.17% | 24.81% | 43.25% | -31.88% | -25.41% | -4.88% | Upgrade |
Free Cash Flow Margin | 3.23% | 6.39% | 5.34% | 4.00% | 6.03% | 7.84% | Upgrade |
Free Cash Flow Per Share | 9.00 | 17.79 | 13.82 | 9.42 | 13.38 | 17.21 | Upgrade |
Cash Income Tax Paid | 880 | 880 | 1,200 | 1,500 | 1,300 | 312 | Upgrade |
Levered Free Cash Flow | 2,474 | 4,060 | 1,633 | 3,612 | 6,461 | 723.5 | Upgrade |
Unlevered Free Cash Flow | 2,880 | 4,448 | 1,973 | 3,928 | 6,808 | 1,094 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.